Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	13.98	35.92	31.51
Graham Fair Price	-79.56	67.67	331.08
PEG	-4339.55	-3.63	-0.08
Price/Book	-3.95	0.83	0.87
Price/Cash Flow	-89.84	17.05	-167.85
Prices/Earnings	2198.79	348.15	15.15
Price/Sales	-8.51	2.91	3.18
Price/FCF	-89.84	17.05	-167.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-4.02	0.28	0.30
Operating Margin	-47.82	0.03	0.05
ROA	-96.03	< 0.005	< 0.005
ROE	0.01	< 0.005	-95.82
ROIC	0.01	< 0.005	-96.25
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.15	-0.07	112.58
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.89	-0.45	-76.07
EPS QOQ	1.85	-0.96	-48.22
FCF QOQ	-1.05	10.46	892.80
Revenue QOQ	-0.05	0.05	2.53
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	107.60	96.55	-10.28
Days Sales Outstanding (DSO)	66.63	61.22	-8.12
Inventory Turnover	0.84	0.93	11.45
Debt/Capitalization	0.30	0.33	10.65
Quick Ratio	0.54	0.79	45.25
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	583.26	583.26	< 0.005
Cash	93.29	160.51	72.05
Capex	-3.08	6.59	113.84
Free Cash Flow	-3.01	28.51	845.70
Revenue	159.11	167.04	4.98
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.95	1.12	18.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.57	8.58	0.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating